Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Expands By 225.0%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 52,000 shares, an increase of 225.0% from the November 15th total of 16,000 shares. Based on an average daily trading volume, of 273,600 shares, the days-to-cover ratio is currently 0.2 days.

Biodexa Pharmaceuticals Stock Performance

Shares of BDRX stock remained flat at $4.45 during trading on Thursday. 18,460 shares of the company traded hands, compared to its average volume of 149,485. The firm has a 50 day simple moving average of $5.40. Biodexa Pharmaceuticals has a one year low of $3.50 and a one year high of $81.03.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.